« Return to News | CROs/Service Providers

ProTrials creates U.K. subsidiary

Tuesday, January 24, 2012 10:40 AM

Sunnyvale, Calif.-based CRO ProTrials Research has created a wholly owned subsidiary to help meet its sponsors’ increasing needs for multi-national, multi-site clinical trials.  Based in the United Kingdom, ProTrials Global will help manage ongoing clinical trials in Italy, Spain and the U.K., and will be responsible for additional growth in the European arena.

Gillian Reid, the company’s newly appointed director of business operations, Europe, will manage ProTrials Global.  With more than 25 years of clinical research experience, Reid previously worked for Charles River Laboratories, Inveresk Research, Napp Laboratories and Merck Sharp & Dohme.  Most recently, she was the director of global key accounts for Chiltern International UK. 

“With ProTrials Global based in the U.K., we are in a stronger position to help sponsors simultaneously conduct clinical trials in North America and Europe, and to guide them in the different complexities for conducting clinical research abroad,” said Jodi Andrews, co-founder and CEO of ProTrials.

Founded in 1996, ProTrials Research is a specialized CRO with regional clinical research associates and project managers based throughout North America, Canada and Europe. It provides site monitoring, project management and associated clinical operations services.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.